Interferon α2b increases MMP-13 and IL-10 expression in Kupffer cells through MAPK signaling pathways

Hepato-Gastroenterology

Volumn 62, Issue 138, 2015, Pages 350-354

  Yu, Zheng ^a   Xie, Man ^a   Fan, Xu ^a   Jia, Jidong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Interferon 2b; Interleukin 10; Kupffer cell; Liver fibrosis. MAPK signaling pathway; Matrix metalloproteinase 13

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA2B INTERFERON; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGENASE 3; INTERLEUKIN 10; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; ALPHA INTERFERON; IL10 PROTEIN, MOUSE; IMMUNOLOGIC FACTOR; MMP13 PROTEIN, MOUSE; PROTEIN KINASE INHIBITOR; RECOMBINANT PROTEIN; TGFB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; KUPFFER CELL; MALE; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SUPERNATANT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; FIBROSIS; IMMUNOLOGY; METABOLISM; TIME;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROSIS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; INTERLEUKIN-10; KUPFFER CELLS; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 13; MICE, INBRED BALB C; PROTEIN KINASE INHIBITORS; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84928552347     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge14263     Document Type: Article

References (19)

1. Poynard T, Massard J, Rudler M., et al.: Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials. Gastroenterol Clin Biol 2009; 33:916-922.
2. Feng L, Kang H, Liu L.N., Cao YM: CD4(+)CD25 (+)Foxp3 (+) Regulatory T Cells Contribute in Liver Fibrosis Improvement with Interferon Alpha. Inflammation 2013; 36:1374-1382.
3. Wynn TA, Barron L: Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30:245-257.
4. Pellicoro A, Ramachandran P, Iredale JP: Reversibility of liver fibrosis. Fibrogenesis Tissue Repair 2012; 5 Suppl 1:S26.
5. Bahcecioglu IH, Koca SS, Poyrazoglu O.K., et al.: Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis. Inflammation 2008; 31:215-221.
6. Zhang LJ, Zheng WD, Shi M.N., Wang XZ: Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver. World J Gastroenterol 2006; 12:1918-1923.
7. Watanabe T, Niioka M, Hozawa S., et al.: Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 2000; 33:224-235.
8. Endo H, Niioka M, Sugioka Y., et al.: Matrix metalloproteinase-13 promotes recovery from experimental liver cirrhosis in rats. Pathobiology 2011; 78:239-252.
9. Fallowfield JA, Mizuno M, Kendall T.J., et al.: Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007; 178:5288-5295.
10. Ramachandran P, Pellicoro A, Vernon MA, et al.: Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A 2012; 109:E3186-E3195.
11. Popov Y, Sverdlov DY, Bhaskar K.R., et al.: Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversai of experimental biliary fibrosis. Am J Physiol Gastrointest Liver Physiol 2010; 298:G323-G334.
12. Ellett JD, Atkinson C, Evans Z.P., et al.: Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10. J Immunol 2010; 184:5849-5858.
13. Schindler C, Plumlee C: Interferons pen the JAK-STAT pathway. Semin Cell Dev Biol 2008; 19:311-318.
14. He SF, Wang W, Ren H., Zhao LJ, Qi ZT: Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cells. Cytokine 2013; 61:801-807.
15. Kim N, Kukkonen S, Martinez-Viedma Mdel P, Gupta S, Aldovini A: Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells. Blood 2013; 121:4090-4100.
16. Yang L, Guo A, Gu JC: c-Jun N-terminal kinase and nuclear factor KB mediate nitric oxide-induced expression of matrix metalloproteinase-13. Int Orthop 2011; 35:1261-1266.
17. Nakai K, Kawato T, Morita T., et al.: Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT (1. receptor in osteoblasts. Biochimie 2013; 95:922-933.
18. Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest 2002; 109:41-50.
19. Chen L, Ye H, Zhao X., Miao Q, Li Y, Hu R: Selective depletion of hepatic Kupffer cells significantly alleviated hepatosteatosis and intrahepatic inflammation induced by high fat diet. Hepatogastroenterology 2012; 59:1208-1212.